Stine Granum
About
Stine Granum is from Oslo, Oslo, Norway. Stine works in the following industries: "Research Services". Stine is currently Director, Head of Vaccine Discovery at Nykode Therapeutics, located in Oslo, Norway. Stine also works as Associate Director of Oncology Research at Vaccibody AS, a job Stine has held since Sep 2020. Another title Stine currently holds is RD Manager/ Sr. Scientist at Vaccibody AS. In Stine's previous role as a Engineer at Department of Immunology at Institute for Cacer Research, Oslo University hospital, Stine worked in Radiumhospital, Oslo until Jul 2015. Prior to joining Department of Immunology at Institute for Cacer Research, Oslo University hospital, Stine was a Engineer at IMB, Department of Anatomy and held the position of Engineer at University of Oslo. Prior to that, Stine was a Researcher at University of Oslo, based in Institute of Basic Medical Sciences (IMB), Department of Anatomy from Jan 2011 to Mar 2014. Stine started working as Postdoc at University of Oslo in IMB, Department of Anatomy in Jan 2008. From Jan 2006 to Jan 2007, Stine was Researcher at University of Oslo, based in IMB, Department of Anatomy.
Stine Granum's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Stine Granum's current jobs
Stine Granum's past jobs
This research is a direct continuing on the work done in my PhD. and Postdoc projects at the group of Professor Anne Spurkland. The projects aim to explore how T cell signaling molecules cross-talk upon T cell activation. The main focus has been to characterize the structure, function and regulation of the adapter protein TSAd, and to analyze how TSAd modulates kinases in the T cell. In particular, Lck, a kinase essential for efficient T cell effector functions. During this period I have been fascinated by the complexity in the immune system, and I have got extensive experience in Immunology and T cell signaling research.